This study identifies a previously unrecognized TSC1/mTORC1-sialylation axis that integrates metabolic regulation and immune checkpoint control, providing mechanistic insights into CRC immune evasion and potential therapeutic avenues for overcoming immunotherapy resistance. The gene discussed is TSC1; the disease is colorectal carcinoma.